Delivery Order SPE2DB24D2101-SPE2DB25FKNMC
Award Date 8/14/25
Potential Completion Date 8/15/25
Potential Value $12K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $2,262.40 to AmerisourceBergen Drug Corp for the supply of Cathflo Activase 2 mg vials, a thrombolytic medication used to restore function to central venous catheters. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of July 29, 2025, and was competitively awarded without set-aside restrictions. AmerisourceBergen's Corporate Office division, headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $16,297.10 to AmerisourceBergen Drug Corp for the supply of Cathflo Activase 2 mg vials, a thrombolytic medication used in medical applications. The contract was executed as a firm fixed-price delivery order on July 31, 2025, with an ultimate completion date of August 1, 2025, and does not include a set-aside designation. Performance will be fulfilled at the vendor's facility in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,374.60 for Cathflo Activase 2 mg vials, effective July 24, 2025, with an ultimate completion date of July 25, 2025. This firm fixed price delivery order was awarded without a set-aside designation through open competition and will be performed at the contractor's Conshohocken, Pennsylvania facility. Cathflo Activase is a thrombolytic agent used in medical settings to restore function to occluded...
- The Defense Logistics Agency awarded a delivery order valued at $12,949.43 to AmerisourceBergen Drug Corp for the supply of Cathflo Activase 2 mg vials under a firm fixed-price contract. This non-set-aside award, issued on July 28, 2025, with an ultimate completion date of July 29, 2025, represents a routine pharmaceutical procurement from the prime contractor's corporate office located in Conshohocken, Pennsylvania. The delivery order is executed under AmerisourceBergen Drug Corp's larger...
- This delivery order, valued at $4,524.80, was awarded to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Cathflo Activase 2 mg vials. The contract is a firm fixed price, non-set-aside award funded by the Defense Logistics Agency (DLA) and is scheduled for completion by July 21, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a discrete purchase under the company's broader pharmaceutical...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,090.40, is for the delivery of 2 mg vials of Cathflo Activase, a medication used to treat certain blood clots. The contract has an ultimate completion date of April 11, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $12,558.77 by the Defense Logistics Agency on July 21, 2025, for the supply of Cathflo Activase 2 mg vials. This contract is structured as a firm fixed price delivery order with no set-aside designation, indicating it was awarded through open competition. The ultimate completion date is scheduled for July 22, 2025, with performance occurring at the contractor's Conshohocken...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Activase 50 mg vials, a thrombolytic medication used in acute medical emergencies. This firm fixed-price delivery order, valued at $3,563.99, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, valued at $999,999,999.00 through December 2026. The contract was...
- This delivery order, issued on August 7, 2025, awards AmerisourceBergen Drug Corp $1,696.80 for the supply of Cathflo Activase 2 mg vials under a firm fixed price contract. The award is funded by the Defense Logistics Agency, a defense-focused component of the Department of Defense responsible for supplying medical and pharmaceutical commodities to military and veteran healthcare systems. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency (DLA) awarded a $11,854.88 delivery order to AmerisourceBergen Drug Corp for the supply of 50 mg vials of Activase, a tissue plasminogen activator used for thrombolytic therapy in acute medical emergencies. This firm fixed-price delivery order, issued on December 6, 2024, with an ultimate completion date of December 9, 2024, was competitively awarded without set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, fulfilled...